GHK-Cu

Name	What it means
Free GHK / prezatide	The three-amino-acid peptide without copper. The COPD model paper used free GHK, not a GHK-Cu treatment in people.120,123
Prezatide copper	The copper complex, also called copper tripeptide-1.124
Prezatide copper acetate / Iamin	A separate acetate form in FDA device records.125,127
5-ALA plus GHK	A copper-free linked hair-study product. It is not GHK-Cu.116

Device clearance

FDA cleared Iamin-2 Hydrating Gel as a topical wound-dressing device in 1997. The record identifies prezatide copper acetate and a wound-cover/protection use. It does not approve an injected GHK-Cu drug.^126,127

Human evidence

No single effect applies across wound gels, cosmetic serums, conjugates and multi-active injections.

Study	What it found
Diabetic ulcers	A randomized evaluator-blinded report found 98.5% median plantar-ulcer closure versus 60.8% with vehicle, and infection in 7% versus 34%, for the immediate topical-product comparison.113
Venous ulcers	Among 86 evaluable participants, 0.4% copper-tripeptide cream did not differ from vehicle. Silver sulfadiazine performed better.114
After laser resurfacing	Thirteen people completed. Objective redness, wrinkles and overall skin quality showed no significant between-group difference; one subjective questionnaire item favored treatment.115
Hair and eyebrows	The 45-person study used 5-ALA plus free GHK. An 18-person eyebrow study tested a 2% serum. A Chinese split-scalp study used three active ingredients. None establishes scalp benefit from GHK-Cu alone.116,118,119

The large injection report used six active ingredients

A 1,000-person uncontrolled hair report used copper tripeptide-1 with five other active ingredients. The study could not isolate GHK-Cu's contribution.¹¹⁷

Laboratory and animal models

The COPD paper profiled gene expression in human lung tissue, then tested free GHK in cultured cells; no participant received GHK-Cu. A rat wound study used biotinylated GHK in a collagen matrix. Neither is a human GHK-Cu treatment result.^120,122

Formulation and delivery

A current review describes GHK-Cu as hydrophilic and skin delivery as a formulation problem.¹²¹

Safety and status

Evidence for a cosmetic ingredient, a wound-dressing device and an injected product applies to each specific product and route.

Injected use

FDA describes limited human safety information for injected GHK-Cu and possible immune reactions from aggregation or peptide impurities. Long-term injection safety and reliable dosing data remain unresolved.¹²⁹

Cosmetic review has limits

A cosmetic panel reviewed several related tripeptides, salts, derivatives and formulations, often at low concentrations. Its conclusion does not establish safety for injections or every modern high-concentration serum.¹³⁰

US status checked in 2026

No FDA-approved GHK-Cu drug was identified in the dated audit. Noninjectable GHK-Cu remains under 503A evaluation; the injectable nomination is withdrawn. That is separate from the 1997 Iamin device clearance.^126,128,129

Specific recalls

Health Canada recalled specified unauthorized GHK-Cu and BPC-157 API lots and warned about online injectable peptide products. A 2015 Iamin family device recall concerned labeling only. These records give no market-wide rate of product mislabeling or contamination.^131,132,133

Common questions

Questions here cover molecule identity, products, routes, results and safety.

01 How long does GHK-Cu take to work, and do results last?

The cited studies cannot yield one general onset or durability estimate for GHK-Cu. They tested different topical products and conditions over different periods. No study cited here established an onset or lasting benefit for injected GHK-Cu.^{113,114,115,118}

02 Does topical evidence apply to injections?

No. The human results concern specific topical products or multi-ingredient formulations. No controlled human study established a benefit or safety profile for injected GHK-Cu alone. A 1,000-person injection report used six active ingredients and no control group.^{113,114,117,129}

03 What do studies say about GLOW, KLOW or other stacks?

The cited evidence does not establish a finished GLOW, KLOW or other multi-ingredient stack. Results for a topical wound product, free GHK, BPC-157 or a thymosin-related material do not prove that an injected blend works or is safe.^113,120,129

04 How should a GHK-Cu vial be mixed or stored?

No source behind this chapter validates reconstitution or storage instructions for an unverified market vial. A topical formulation, a cleared wound-dressing device and an injectable powder are different products. Instructions for an identified regulated product apply to that product; a pharmacist or clinician can clarify them when they are unclear.^121,127,129

05 What injection dose, frequency or cycle has been tested?

No evidence-based injection regimen for GHK-Cu alone was found in these sources. Topical concentrations and a multi-ingredient intradermal formulation cannot supply a dose for an injected market vial.^114,117,129

06 How can I know what a product sold as GHK-Cu contains?

A label is not an identity test. Free GHK, the copper complex, the acetate form, conjugates and blends are different materials. The records do not provide a market-wide independent testing rate. A Canadian recall concerned specified unauthorized API lots and cannot be generalized to every product.^{123,124,125,131} A non-peer-reviewed voluntary dataset included one GHK-Cu-labeled report without the named peptide; one report is not a market rate, and chromatographic purity does not establish sterility or endotoxin status.¹³⁷

07 How common are injection-site reactions?

A reliable rate was not identified. Forum reports have no verified product identity or denominator. FDA describes limited human safety information and possible immune-reaction concerns from aggregation or peptide impurities, but that is a hazard concern rather than a measured incidence rate.¹²⁹

08 Does GHK-Cu improve skin?

The human evidence cited here does not support one broad skin-rejuvenation claim. In 13 people after laser resurfacing, objective redness, wrinkles and overall skin quality showed no significant between-group difference; one subjective questionnaire item favored treatment. Cosmetic and wound products use different formulations.^115,121,130 Three later uncontrolled reports tested multi-ingredient scalp, scar-gel and cream regimens; none isolates a GHK-Cu effect.^134,135,136

09 Is GHK-Cu safe?

Safety depends on the exact material, vehicle, concentration, route and use. The cosmetic review does not establish safety for injections or every modern product. Long-term injected use, pregnancy, interactions, sterility, potency, endotoxin and degradation remain unresolved in these sources.^129,130,132

10 Does GHK-Cu regrow scalp hair?

The cited studies cannot attribute scalp-hair regrowth to GHK-Cu alone. A 45-person study tested 5-ALA with free GHK. A 1,000-person report used six injected actives. An 18-person eyebrow study tested a serum, and a Chinese split-scalp study used three ingredients. None isolates a scalp or injection effect from GHK-Cu alone.^{116,117,118,119}

11 Does it help wounds or scars?

Human wound findings are mixed and product-specific. A randomized diabetic-ulcer report found better outcomes for an immediate topical product, while a 0.4% copper-tripeptide cream trial in venous ulcers found no difference from vehicle. A rat study used biotinylated GHK in a collagen matrix.^113,114,122

12 Do I need copper or zinc testing?

The records do not validate a laboratory-monitoring schedule for unapproved GHK-Cu injections. They also do not establish an injection dose against which a result could be interpreted. A clinician can decide whether symptoms, history, supplements or another exposure justify testing.¹²⁹

13 Are GHK, GHK-Cu, copper tripeptide-1 and Iamin the same?

No. Free GHK is prezatide. Prezatide copper is the copper complex. Prezatide copper acetate is a separate form used in Iamin records. A name still does not identify the concentration, vehicle, route or finished product.^{123,124,125,127}

14 Does the serum or delivery system matter?

Yes. GHK-Cu is hydrophilic, and a current review treats skin permeation as a formulation problem. That supports checking the exact vehicle and delivery system; it does not prove that liposomes, microneedling or another method improves clinical outcomes.¹²¹

15 Is GHK-Cu FDA approved?

No FDA-approved GHK-Cu drug appears in the dated records. FDA cleared Iamin-2 Hydrating Gel as a wound-dressing device in 1997; that clearance gives no injectable drug approval. As checked in 2026, noninjectable GHK-Cu remained under 503A evaluation while the injectable nomination was withdrawn.^{126,127,128,129}

16 Did the COPD study give GHK-Cu to people?

No. Researchers measured gene expression in lung tissue, then tested free GHK in cultured cells. No person received GHK-Cu.¹²⁰